EXIT071 (EXosomes Isolation Tool developed @Leiden) – an innovative startup developing pioneering technology for the analysis of novel biomarkers exosomes. All cells in our body make exosomes to send messages to other cells. Cells pack these tiny bubbles with their own molecular information and excrete them into all body fluids – blood, urine and even tears! Using exosomes make diagnostics very specific. This is why exosomes have a huge potential for non-invasive diagnostics and novel therapeutics. At EXIT071 we develop microfluidic technology that allows for the isolation and analysis of exosomes with high purity and in high-throughput automated format.
| Website | http://www.exit071.com |
| Employees | 7 (5 on RocketReach) |
| Founded | 2021 |
| Address | Langegracht 70, Leiden, South Holland 2312NV, NL |
| Industry | Research |
| Keywords | Research Tools, Clinical Diagnostics, Biomarker Analysis, Cellular Communication, Liquid Biopsy, Precision Medicine, Diagnostic Tools, Therapeutic Targets, Drug Discovery, Proteomics, Nanotechnology, Cell Analysis, Molecular Diagnostics, Biotechnology, Medical Technology, Life Sciences |
| Competitors | Eclipse Events, Mix Masters Inc, Sound City Inc., BeatHive LLC, The Release, Instaparty, Event Horizon, Pulse Inc, Racket, Ignite Productions Inc +2 more (view full list) |
Looking for a particular EXIT071 employee's phone or email?
Andrea Capuano is the CTO of EXIT071.
5 people are employed at EXIT071.
EXIT071 is based in Leiden, South Holland.